Cancer Research The Future of Cancer Research: Science and Patient Impact  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 30, 966-973, April 1, 1970]
© 1970 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Silvestrini, R.
Right arrow Articles by Dasdia, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Silvestrini, R.
Right arrow Articles by Dasdia, T.

Interference of Daunomycin with Metabolic Events of the Cell Cycle in Synchronized Cultures of Rat Fibroblasts1

R. Silvestrini2, A. Di Marco and T. Dasdia

Istituto Nazionale per lo Studio e la Cura dei Tumori, Sezione di Chemioterapia Sperimentale, Milan, Italy

The influence of daunomycin on nucleic acid synthesis during different stages of the cell cycle has been studied in mammalian cells. Explants from leg muscle of newborn rats were synchronized by two 24-hr treatments with excess thymidine, 16 hr apart. The metabolic activity of DNA and RNA was determined by autoradiographic methods by measuring the incorporation of thymidine-3H, deoxycytidine-3H, and uridine-3H into nuclear structures. In control cultures, DNA synthesis shows two distinct waves located in the early and late S phase, the latter being the most sensitive to the inhibiting effect of daunomycin. RNA synthesis takes place in the cells during the entire cell cycle from the end of mitosis to the late prophase, but two well-defined peaks can be recognized: the first in the G2 phase just 1 or 2 hr before the mitotic peak and the second in the middle stages of G1. These RNA syntheses involving both nucleolar and extranucleolar structures are strongly inhibited by daunomycin treatment. The significance of these RNA syntheses in control cells and the relationship between their inhibition and the antimitotic effect of daunomycin are discussed.

1 These investigations were supported in part by the "Consiglio Nazionale delle Ricerche," Italia.

2 Consiglio Nazionale delle Ricerche.

Received 7/ 8/69. Accepted 9/22/69.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1970 by the American Association for Cancer Research.